The Chemours Company (NYSE:CC) traded with the volume of 2.39 Million Yesterday. The Stock Opened its session at $16.29 and closed at $15.75 by showing an decrease of -2.78 percent. The Chemours Company has 1 year price target of 13.71. The stock gained a consensus recommendation of 2.6 on Zacks Investment Research where the scale runs from 1 to 5, 1 representing Strong buy and 5 showing Strong Sell. The company is expected to report its next EPS (earnings per share) on Nov 03 AMC.  The company reported its last quarter on Jun 16.

On Jun 16 The Chemours Company (NYSE:CC) reported its EPS in the last quarter as $0.27/Share beating the analyst estimate of $0.17/Share by the difference of $0.1. This showed the surprise of 58.8% in the last quarter earnings. For the Current Quarter, 2 analyst are projecting the mean EPS to be $0.17/share. According to their observations and findings, the stock could provide a high EPS of $0.19/share and a Low EPS of $0.15/share.

The 8 analysts offering 12-month price forecasts for Chemours Co have a median target of 12.50, with a high estimate of 20.00 and a low estimate of 4.00. The median estimate represents a -20.63% decrease from the last price of 15.75. (CNN MONEY)

Many Analysts provided their foresight on Revenue Estimates of The Chemours Company where they believe that the company has the potential to earn average revenue of $1.4 Billion for the current quarter. According to their predictions High & Low revenue estimates are 1.44 Billion and 1.38 Billion respectively.

The Chemours Company (NYSE:CC) topped its 52-week high price of $16.32 on Oct 6, 2016 and 52-Week Low Price of $3.06 on Jan 27, 2016. The Stock currently has the market capitalization of $2.94 Million, P/E (price to earnings ttm) of 0 and Weekly volatility of 3.15%% and monthly volatility of 4.49%% respectively.

The Chemours Company Gross Margin percentage stands at 17.1% while its Operating Margin for trailing twelve month is -2.5 percent and Profit margin (ttm) is -1.5 Percent. The stock is currently moving above its 20-Day Simple Moving Average of 22.47% with the 50-Day Simple Moving Average of 22.47 percent. Currently, the company has SMA200 (200-day simple moving average) of 84.84 Percent. The Stock has YTD (year to date) performance of 196.98 percent.

Many research firms have provided their ratings on The Chemours Company (NYSE:CC) where Goldman provided Buyrating on the stock on 14-Mar-16. Other firms include Jefferies giving Hold rating on 16-Feb-16.

The latest Insider trade was made on 29 Jun 2016 where Trojanowski (Amy) Officer did a transaction type “Sell” in which 43 shares were traded at a price of $8.24. Another insider trade includes Chief Executive Officer Vergnano (Mark P) who also initiated a transaction in which 191 shares were traded on 29 Jun 2016 as “Sell”.

Company Profile:

Chemours Company is involved in chemical business. It operating segment consists of Titanium Technologies, Fluoroproducts and Chemical Solutions. Titanium Technologies segment produces titanium dioxide and premium white pigment. Fluoroproducts segment provides fluoroproducts, refrigerants and industrial fluoropolymer resins. Chemical Solutions segment provides industrial and specialty chemicals. The company’s brand consists of Teflon(R), Ti-Pure(R), Krytox(R) Viton(R), Opteon(R) and Nafion(R). Chemours Company is headquartered in Wilmington.